Medtronic Inc.: Medical Device Recall in 2021 - (Recall #: Z-1617-2021)

Updated on March 25, 2026.

See the recall detail below. You can also see other recalls from the same firm in 2021.

Data Source: FDA.

Product Description:

Medtronic, REF: MMT-7008C, Enlite Glucose Sensor for the following packaging: ENLITE AUS 1 PRESS 5PK/ GTIN: 20763000252032 Product Usage: intended for use with Medtronic Diabetes (Medtronic) glucose sensing systems to continuously monitor glucose levels in persons with diabetes. *Product not distributed within US.

Product Classification:

Class II

Date Initiated: February 26, 2021

Date Posted: May 26, 2021

Recall Number: Z-1617-2021

Event ID: 87476

Reason for Recall:

Use of the continuous glucose monitoring system while actively taking hydroxyurea, an anti-neoplastic drug could result in inaccurate elevated sensor glucose readings.

Status: Ongoing

Product Quantity: 1,174 units

Code Information:

All Lot numbers within active shelf life

Distribution Pattern:

Worldwide distribution.

Voluntary or Mandated:

Voluntary: Firm initiated